When members of the Neurointensive Care (Neuro ICU) Unit at the UCSF Medical Center started receiving the ALS Ice Bucket Challenge from various sources, they jumped at the chance to accept the challenge and to donate to ALS research.
August 26, 2014
August 22, 2014
On a cold and windy afternoon at the Parnassus campus, UCSF Chancellor Sam Hawgood, MBBS, accepted the #ALSIceBucketChallenge, dunking himself in ice water and making a personal donation to the ALS Association.
June 03, 2014
The New York Times Health for Tomorrow conference, held at UCSF, featured experts from the University of California and across the country, addressing the changing landscape of health care.
May 27, 2014
Funded through President Obama's Brain Initiative, a UCSF-led team is embarking on a $26 million project to develop a revolutionary and long-lasting treatment for depression, anxiety disorders, addiction and other neuropsychiatric disorders.
May 15, 2014
As players from a wide range of industries continue to venture into health and health care, it will be imperative for UCSF to form new partnerships to address familiar health challenges in creative, novel ways.
April 17, 2014
Nobel Prize winner Stanley Prusiner is closing in on better treatments for Alzheimer's, Parkinson's and other brain diseases, and an unlikely new partnership will get him there faster.
April 15, 2014
Four UCSF-affiliated researchers are among 102 recipients of the Presidential Early Career Awards for Scientists and Engineers.
March 20, 2014
Researchers are recording brain activity in visually stunning ways that could lead to targeted therapies for Alzheimer’s, autism and other diseases.
November 15, 2013
Precision Medicine Pillar No. 3: Clinical Discovery. Researchers are taking vast amounts of patient data, often collected through first-ever clinical studies, and putting it into tools like MS Bioscreen that have a direct impact on patient care.
October 14, 2013
Through support from the Catalyst Awards, UCSF researcher Aditi Bhargava is working to develop a method for delivering small-molecules to a specific target group of cells for treatment of pain.